PharmaShots | Incisive News in 3 Shots

Subscribe Now

Amryt

Amryt’s Mycapssa Receives the EMA’s COMP Positive Opinion Recommending Orphan Disease Designation for the Treatment of Acromegaly

Amryt’s Mycapssa Receives the EMA’s COMP Positive Opinion Recommending Orphan Disease Designation for the Treatment of Acromegaly

October 19, 2022

Amryt Receives CHMP Positive Opinion of Filsuvez for the Treatment of Dystrophic and Junctional EB

Amryt Receives CHMP Positive Opinion of Filsuvez for the Treatment of Dystrophic and Junctional EB

April 25, 2022

Amryt Reports Results of Mycapssa in P-III (MPOWERED) Study for the Treatment of Acromegaly

Amryt Reports Results of Mycapssa in P-III (MPOWERED) Study for the Treatment of Acromegaly

January 12, 2022

Amryt Publishes Results of Mycapssa in P-III (MPOWERED) Trial for the Treatment of Acromegaly in The Lancet Diabetes & Endocrinology

Amryt Publishes Results of Mycapssa in P-III (MPOWERED) Trial for the Treatment of Acromegaly in The Lancet Diabetes & Endocrinol...

January 5, 2022

PharmaShots Weekly Snapshots (Mar 29 - Apr 02, 2021)

PharmaShots Weekly Snapshots (Mar 29 - Apr 02, 2021)

April 2, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us